Bioretec
1,835
EUR
-3,42 %
1.555 følger denne virksomhed
BRETEC
First North Finland
Medical Equipment & Services
Health Care
Overview
Finansielt overblik og estimater
Investor consensus
-3,42%
-17,43%
-18,48%
-20,18%
-14,86%
-26,32%
-6,55%
-
-34,85%
Bioretec is a medical technology company. The company specializes in the development of medical devices. The product portfolio includes, for example, implants for pediatric and adult orthopedics and other material for bone and soft tissue injuries. In addition to the main business, service and associated ancillary services are also offered. Bioretec operates worldwide with the largest presence in the Nordic region.
Læs mereMarkedsværdi
56,49 mio. EUR
Aktieomsætning
27,63 t EUR
P/E (adj.) (25e)
-11,45
EV/EBIT (adj.) (25e)
-11,01
P/B (25e)
4,18
EV/S (25e)
6,92
Udbytteafkast, % (25e)
-
Omsætning og EBIT-margin
Omsætning mio.
EBIT-% (adj.)
EPS og udbytte
EPS (adj.)
Udbytte %
Finanskalender
14.8
2025
Delårsrapport Q2'25
13.11
2025
Selskabsgennemgang Q3'25
Risiko
Business risk
Valuation risk
Lav
Høj
Alle
Analyse
Selskabspræsentationer
Selskabsmeddelelser
ViserAlle indholdstyper
New shares of Bioretec Ltd subscribed with option rights have been registered with the trade register
Inside information: Sarah van Hellenberg Hubar-Fisher appointed interim CEO of Bioretec
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools